Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Danhuang Longxin
- Development stage
- Unknown
- Lead developer
- Guizhou Yibai Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Danhuang Longxin (also known as Danhuang Longbi) is a Traditional Chinese Medicine (TCM) capsule developed and manufactured by Guizhou Baixiang Pharmaceutical. It is specifically indicated for the treatment of chronic prostatitis and benign prostatic hyperplasia (BPH). The formulation is composed of several herbal ingredients, including *Salvia miltiorrhiza*, *Phellodendron amurense*, and *Vaccaria segetalis*, which work synergistically to clear heat, remove dampness, and promote blood circulation. Mechanistically, the drug is thought to reduce the production of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6), and inhibit cyclooxygenase-2 (COX-2) activity, thereby alleviating pelvic pain, urinary frequency, and urgency. It is widely used in China as a standard treatment for chronic pelvic pain syndrome (CPPS) related to prostate inflammation.
- Brand names
- Danhuang LongxinDanhuang Longbi
- Other names
- Danhuang Longbi Capsules丹黄隆闭胶囊
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)IL-6 (Interleukin 6)TNFA (Tumor necrosis factor alpha (soluble))
Beyond the preview
Go deeper on Danhuang Longxin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Danhuang Longxin.